Skip to main navigation Skip to search Skip to main content

Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism

  • The RIETE Investigators
  • Department of Internal Medicine
  • Hospital de Madrid Norte Sanchinarro
  • Department of Internal Medicine
  • Hospital Universitario La Paz
  • Department of Pneumonology
  • Hospital de Galdakao
  • Department of Internal Medicine
  • Ospedale SS. Giovanni e Paolo di Venezia
  • Department of Vascular Medicine and Arterial Hypertension
  • Assistance publique - Hôpitaux de Marseille
  • Department of Internal Medicine
  • Hospital General Universitario de Elda
  • Rebecca Sieff Government Hospital
  • Chair for the Study of Thromboembolic Disease
  • Universidad Católica San Antonio de Murcia

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

The clinical significance and optimal therapy of patients with subsegmental pulmonary embolism (SSPE) remain controversial. We used the data in the RIETE Registry to compare the baseline characteristics, treatment, and outcomes during anticoagulation and after its discontinuation in patients with asymptomatic vs. symptomatic SSPE. From January 2009 to September 2022, there were 2135 patients with a first episode of SSPE, of whom 160 (7.5%) were asymptomatic. Most patients in both subgroups received anticoagulant therapy (97% vs. 99.4%, respectively). During anticoagulation, 14 patients developed symptomatic pulmonary embolism (PE) recurrences, 28 lower-limb deep vein thrombosis (DVT), 54 bled, and 242 died. The patients with asymptomatic SSPE had similar rates of symptomatic PE recurrences (hazard ratio (HR): 2.46; 95% CI: 0.37–9.74), DVT (HR: 0.53; 95% CI: 0.03–2.80), or major bleeding (HR: 0.85; 95% CI: 0.21–2.42) to those with symptomatic SSPE, but had a higher mortality rate (HR: 1.59; 95% CI: 1.25–2.94). The rate of major bleeding outweighed the rate of PE recurrences (54 major bleeds vs. 14 PE recurrences), and the rate of fatal bleeds outweighed the rate of fatal PE recurrences (12 vs. 6 deaths). After discontinuing anticoagulation, the patients with asymptomatic SSPE had a similar rate of PE recurrences (HR: 1.27; 95% CI: 0.20–4.55) and a non-significantly higher mortality rate (HR: 2.06; 95% CI: 0.92–4.10). The patients with asymptomatic SSPE had similar rates of PE recurrences to those with symptomatic SSPE, during and after discontinuing anticoagulation. The unexpectedly higher rate of major bleeding than recurrences highlights the need for randomized trials to find the best management.

Original languageEnglish
Article number1640
JournalJournal of Clinical Medicine
Volume12
Issue number4
DOIs
StatePublished - 18 Feb 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023 by the authors.

Keywords

  • anticoagulants
  • bleeding
  • pulmonary embolism
  • venous thrombosis

Fingerprint

Dive into the research topics of 'Clinical Significance and Outcome in Patients with Asymptomatic Versus Symptomatic Subsegmental Pulmonary Embolism'. Together they form a unique fingerprint.

Cite this